Atlas Trials

17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery

Clinical trial NCT00248521 · UNKNOWN

Trial details

NCT number
NCT00248521
Sponsor
Institute of Cancer Research, United Kingdom
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Unspecified Adult Solid Tumor, Protocol Specific
Start date
2005-10-01
Primary completion
2007-01-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.